Great analysis!But I think we have to include Greenbushes & Kwinana into IGO's valuation and they have no debt in fact.Hope to get $4 per share as well
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%